Innov8 Group Holdings

Innov8 Group Holdings is a South African private equity firm specializing in funding innovative medical technologies within the African medical industry. The firm focuses on identifying and supporting early-stage and growth-stage companies that are developing cutting-edge solutions to address healthcare challenges across the continent. By providing capital and strategic guidance, Innov8 aims to accelerate the commercialization and scalability of these technologies, thereby improving healthcare access and outcomes in Africa. The firm's investment strategy encompasses a broad geographical focus, targeting countries such as South Africa, Kenya, Nigeria, Egypt, Ghana, Ethiopia, Tanzania, Uganda, Algeria, Sudan, Angola, Morocco, Mozambique, Madagascar, Cameroon, Côte d'Ivoire, Niger, Burkina Faso, Mali, and Malawi. This extensive reach allows Innov8 to tap into diverse healthcare markets and address a wide range of medical needs. The industries they invest in include healthcare, technology, biotechnology, medical devices, digital health, telemedicine, pharmaceuticals, diagnostics, health insurance, medical equipment, health IT, health services, medical research, health education, and medical logistics. Innov8 Group Holdings has demonstrated a strong track record in the private equity sector, particularly within the healthcare and technology domains. Their portfolio includes companies such as MyPocketHealth, a virtual care platform; Innohealth Clinics, a rapidly digital-first, doctor-led, affordable primary care provider; AI Biologics Africa, an AI biotechnology platform; and Social Medical, a healthcare marketing agency. These investments reflect Innov8's commitment to fostering innovation and improving healthcare delivery across Africa. The firm's founders, Dr. Chad Marthinussen and Abdul Malick Salie, bring nearly three decades of combined experience in corporate finance, investment, healthcare, and technology industries, positioning Innov8 as a key player in advancing Africa's healthtech landscape.

Innovative medical technologies, Early-stage and growth-stage companies, Scalable solutions addressing healthcare challenges in Africa, Strong management teams with a clear vision, Potential for significant impact on healthcare access and outcomes